Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
I-Mab Announces First Patient Dosed in U.S. Phase 1 Study of Protollin for the Treatment of Alzheimer's Disease 2021-12-08 21:00
Nippon Express (Nederland) Acquires GDP Compliance Certification for Company-owned Warehouse 2021-12-08 14:00
China's Largest Commercial GMP Plasmid Manufacturing Facility is Put into Operation, GenScript ProBio Expanding Manufacturing Capacity Again 2021-12-07 21:33
Global Cord Blood Corporation Announces Results of 2021 Annual General Meeting 2021-12-07 21:32
IT Tech Packaging, Inc. Officially Starts its Surgical Masks Production 2021-12-07 21:30
VR Digital Therapeutics for depression developed in consultation with specialists from Boston, MA, U.S.A., introducing innovative clinical tool at CES2022 2021-12-07 21:00
I-Mab to Pursue Dual Listing Plan on The Main Board of The Stock Exchange of Hong Kong Limited 2021-12-07 21:00
SyMap Medical Ltd. Closes Largest Financing Round in Renal Denervation Field 2021-12-07 20:30
Samsung Biologics adds to global ISO certifications with Quality Management System 2021-12-07 13:04
Akeso Announces Launch of U.S. Investigator-Initiated Study of Cadonilimab (PD-1/CTLA-4 Bispecific Antibody) 2021-12-07 08:20
Happiness Development Exported $1.2 million Lucidum Products 2021-12-07 01:00
IMPACT 2021 R&D Day: Synthetic Lethality Provides a New Platform for Targeted Cancer Therapy 2021-12-06 16:03
Odyssey Announces Agreement to Combine with BenevolentAI 2021-12-06 14:00
Jacobio Receives IND Approval for Combination Therapy of KRAS G12C and Cetuximab Injection in China 2021-12-06 09:16
Kazia Announces Positive Final Data From Phase II Clinical Study Of Paxalisib In Newly Diagnosed Glioblastoma 2021-12-04 21:00
I-Mab Announces First Two Patients Dosed in U.S. Phase 2 Combination Trial of Uliledlimab with Atezolizumab in Patients with Selected Advanced Solid Tumors 2021-12-03 21:00
OrigiMed announced its strategic partnership with Janssen to develop clinical innovative solutions driven by data science 2021-12-03 17:01
Biotheus' Bifunctional Therapeutic PM8001 has been Approved by the USFDA to Enter Phase II Studies 2021-12-03 16:23
InnoCare Announces Inclusion of Orelabrutinib in China National Reimbursement Drug List 2021-12-03 10:13
Hepagene Therapeutics Initiates the RISE Study, a Phase IIa Clinical Trial of HPG1860 in Patients with NASH 2021-12-02 23:00
1 185 186 187 188 189 802